1. Ahmad, J., Hasnain, S.E., Siddiqui, M.A., Ahamed, M., Musarrat, J., and Al-Khedhairy, A.A., MicroRNA in carcinogenesis and cancer diagnostics: a new paradigm, Indian J. Med. Res., 2013, vol.137, no. 4, p. 680.
2. Alhasan, A.H., Scott, A.W., Wu, J.J., Feng, G., Meeks, J.J., Thaxton, C.S., and Mirkin, C.A., Circulating microRNA signature for the diagnosis of very high-risk prostate cancer, Proc. Natl. Acad. Sci. U. S. A., 2016, vol. 113, no. 38, pp. 10655–10660.
3. Ambs, S., Prueitt, R.L., Yi, M., Hudson, R.S., Howe, T.M., Petrocca, F., Wallace, T.A., Liu, C.-G., Volinia, S., and Calin, G.A., Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer, Cancer Res., 2008, vol. 68, no. 15, pp. 6162–6170.
4. Anastas, J.N. and Moon, R.T., WNT signalling pathways as therapeutic targets in cancer, Nat. Rev. Cancer, 2013, vol. 13, no. 1, p. 11.
5. Arunkumar, G., Rao, D.M., Kuha, A., Manikandan, M., Prasanna Srinivasa Rao, H., Subbiah, S., Ilangovan, R., Murugan, A.K., and Munirajan, A.K., Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma, Oncol. Lett., 2018, vol. 15, no. 1, pp. 649–657.